Cosmos Pharmaceutical Co., Ltd.
Cosmos Pharmaceutical Co., Ltd. is a Private limited company (Ltd.) registered in Japan under 9290001025414, and its current status with National Tax Agency — Corporate Number Publication Site is active. The company was incorporated on 5 October 2015 and lists its registered address as Fukuoka City Hakata Ward, Japan. 4 shareholders are on record for Cosmos Pharmaceutical Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from National Tax Agency — Corporate Number Publication Site and was last updated on 30 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
4
Shareholders of Cosmos Pharmaceutical Co., Ltd.
Four shareholders are currently on record for Cosmos Pharmaceutical Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund, holding 12.1% — the largest recorded stake — followed by iShares Trust-iShares MSCI EAFE Small-Cap ETF at 5.2%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund | 12.1% | National Tax Agency — Corporate Number Publication Site | |
| iShares Trust-iShares MSCI EAFE Small-Cap ETF | 5.2% | National Tax Agency — Corporate Number Publication Site | |
| SCHWAB STRATEGIC TRUST-Schwab International Equity ETF | 3.5% | National Tax Agency — Corporate Number Publication Site | |
| VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Index Fd. | 3.4% | National Tax Agency — Corporate Number Publication Site |
Officers
2
Directors and officers of Cosmos Pharmaceutical Co., Ltd.
Two officers are currently on record for Cosmos Pharmaceutical Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Futoshi Shibata serves as Gm Of Corporate Planning Department & Director; Hideaki Yokoyama serves as President & Representative Director. Management authority at Cosmos Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Group Structure
Group structure of Cosmos Pharmaceutical Co., Ltd.
Cosmos Pharmaceutical Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- GREEN FLASH, K.K. (Japan)
Data availability
Those 1 subsidiary spans Japan jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Data-provider feed — rows as supplied to Zavia for National Tax Agency — Corporate Number Publication Site, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Cosmos Pharmaceutical Co., Ltd.
Japan
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Cosmos Pharmaceutical Co., Ltd.?
Four shareholders are currently on record for Cosmos Pharmaceutical Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund, holding 12.1% — the largest recorded stake — followed by iShares Trust-iShares MSCI EAFE Small-Cap ETF at 5.2%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Cosmos Pharmaceutical Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Cosmos Pharmaceutical Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Cosmos Pharmaceutical Co., Ltd. have on record?
4 shareholders are shown on record for Cosmos Pharmaceutical Co., Ltd..
What is Cosmos Pharmaceutical Co., Ltd.'s company registration number?
Cosmos Pharmaceutical Co., Ltd.'s registration number is 9290001025414, filed with National Tax Agency — Corporate Number Publication Site in Japan. Its current status on the register is active.
Is Cosmos Pharmaceutical Co., Ltd. still an active company?
Cosmos Pharmaceutical Co., Ltd.'s status on National Tax Agency — Corporate Number Publication Site is listed as active.
When was Cosmos Pharmaceutical Co., Ltd. incorporated?
Cosmos Pharmaceutical Co., Ltd. was incorporated on 5 October 2015, according to National Tax Agency — Corporate Number Publication Site.
What is Cosmos Pharmaceutical Co., Ltd.'s registered address?
The registered address on file for Cosmos Pharmaceutical Co., Ltd. is Fukuoka City Hakata Ward, Japan.
What legal structure is Cosmos Pharmaceutical Co., Ltd. registered as?
Cosmos Pharmaceutical Co., Ltd. is registered as a Private limited company (Ltd.) in Japan.
Who are the officers/directors of Cosmos Pharmaceutical Co., Ltd.?
Two officers are currently on record for Cosmos Pharmaceutical Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Futoshi Shibata serves as Gm Of Corporate Planning Department & Director; Hideaki Yokoyama serves as President & Representative Director. Management authority at Cosmos Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Cosmos Pharmaceutical Co., Ltd. have a parent company or subsidiaries?
Cosmos Pharmaceutical Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Those 1 subsidiary spans Japan jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Cosmos Pharmaceutical Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from National Tax Agency — Corporate Number Publication Site. Zavia's monitoring API can track changes to Cosmos Pharmaceutical Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Cosmos Pharmaceutical Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Japan, so records like Cosmos Pharmaceutical Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from National Tax Agency — Corporate Number Publication Site and was last synced on 30 September 2026.